Effect of Food on the Pharmacokinetics of Quizartinib

Quizartinib is an oral, highly potent, and selective type II FMS‐like tyrosine kinase 3 inhibitor in development for acute myeloid leukemia. This parallel‐group study evaluated potential food effects on quizartinib absorption in healthy subjects who received a single 30‐mg dose after overnight fasti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianke, Holmes, Melissa, Kankam, Martin, Trone, Denise, Mendell, Jeanne, Gammon, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027461/
https://www.ncbi.nlm.nih.gov/pubmed/31916418
http://dx.doi.org/10.1002/cpdd.770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027461/
https://www.ncbi.nlm.nih.gov/pubmed/31916418
http://dx.doi.org/10.1002/cpdd.770

Ejemplares similares